Jones Financial Companies
PRME icon

Jones Financial Companies’s Prime Medicine PRME Stock Holding History

Jones Financial Companies’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Buy
40,867
+560
+1% +$1.86K ﹤0.01% 2722
2026
Q1 		$136K Sell
40,307
-96
-0.2% -$365 ﹤0.01% 2544
2025
Q4 		$140K Buy
40,403
+30,828
+322% +$137K ﹤0.01% 2078
2025
Q3 		$49K Buy
+9,575
New +$38.9K ﹤0.01% 2389

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Jones Financial Companies's PRME Position: Q2 2026 in Review

Jones Financial Companies increased its Prime Medicine (PRME) stake by 1.4% in Q2 2026, buying an estimated $1.86K and bringing the position to 40,867 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #2722.

Jones Financial Companies first reported a position in PRME in Q3 2025 and has held it in 4 quarters since. The position peaked at $140K in Q4 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Jones Financial Companies held 40,867 shares of Prime Medicine worth $140K as of Q2 2026.
  • Jones Financial Companies bought 560 Prime Medicine shares in Q2 2026, an estimated $1.86K.
  • Prime Medicine made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2722 holding.
  • Jones Financial Companies first reported a position in Prime Medicine in Q3 2025 and has held it in 4 quarters since.
  • Jones Financial Companies's Prime Medicine position peaked at $140K in Q4 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.